HIV: Inflammation and Bone

Increasing Clarity on Bone Loss Associated With Antiretroviral Initiation

(2011) M. T. Yin et al.   JOURNAL OF INFECTIOUS DISEASES

Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans

(2011) Julie A. Womack et al.   PLoS One

HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture

(2011) Ighovwerha Ofotokun et al.   Current Opinion in Endocrinology Diabetes and Obesity

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

(2010) Anna Bonjoch et al.   AIDS

HIV and bone disease

(2010) Benjamin Stone et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

(2010) Hans‐Jürgen Stellbrink et al.   CLINICAL INFECTIOUS DISEASES

Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers

(2010) Grace A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial*

(2010) AB Hansen et al.   HIV MEDICINE

The multiple faces of autoimmune-mediated bone loss

(2010) Georg Schett et al.   Nature Reviews Endocrinology

Mechanisms of impaired bone strength in type 1 and 2 diabetes

(2010) D. Merlotti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats

(2010) T. Vikulina et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Early Immune Senescence in HIV Disease

(2010) Seema Desai et al.   Current HIV/AIDS Reports

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

(2009) Claudine Duvivier et al.   AIDS

A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner

(2009) Leonard Rifas et al.   ARTHRITIS AND RHEUMATISM

Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

(2009) Todd T Brown et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation

(2009) Yi Tang et al.   NATURE MEDICINE

Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease

(2009) Anjana Yadav et al.   VIROLOGY

A Splenic Marginal Zone-Like Peripheral Blood CD27+B220− B Cell Population Is Preferentially Depleted in HIV Type 1-Infected Individuals

(2008) Matthew Morrow et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis

(2008) Patrizia D'Amelio et al.   BONE

Fracture Prevalence among Human Immunodeficiency Virus (HIV)-InfectedVersusNon-HIV-Infected Patients in a Large U.S. Healthcare System

(2008) Virginia A. Triant et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals

(2008) Susan Moir et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-  and IL-17

(2008) M. Hashizume et al.   RHEUMATOLOGY

Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection

(2008) Julien van Grevenynghe et al.   SEMINARS IN IMMUNOLOGY